← Leaderboards
Emily Pinheiro
Northwestern University At Chicago
$129,272
Attributed
$129,272
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $45.5K · FY2020–22$50K$37.5K$25K$12.5K$0
'20
'21
'22
Funding mix
By agency
NIH$129,272 · 1
By mechanism
F31$129,272 · 1
Top collaborators
No co-investigators on record.
Most similar at Northwestern University At Chicago
Same institution · by research overlap
- Melina Rae Kibbe$9,200,692
- Kristan A. Leech$1,811,596
- Brian T Emmer$2,838,158
- June M. McKoy$737,071
- Chonghui Cheng$7,932,847
Others in their field
Other Emerging Leaders on “Adverse Effects”
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Kristin Aillon · Midwest Research Institute$23,644,534
- Abraham Aizer Brody · New York University School Of Medicine$21,887,280
- Ellen Gould Chadwick · Harvard University D/B/A Harvard School Of Public Health$21,828,548
- Ionut Bebu · George Washington University$18,816,779
- Barbara Halina Braffett · George Washington University$18,816,779
Research focus
Adverse EffectsAffectAmputationAtherosclerosisBiochemicalBlindedBlood PressureCardiac MyocytesCardiovascular Risk FactorCase-By-Case BasisCausal VariantCell LineCellsChronic Myeloid LeukemiaCoronary Heart DiseaseCrispr/Cas TechnologyCytogeneticsDesignDifferential ExpressionDisease RemissionDisorder RiskDrug DiscoveryDrug ExposureAdverse Drug Reaction
Grant awards (3)
A Patient-Specific hiPSC Model of Nilotinib-Induced Peripheral Artery Disease Pharmacogenomics$42,459
F31 · FY2022 · HL · contact PI
A Patient-Specific hiPSC Model of Nilotinib-Induced Peripheral Artery Disease Pharmacogenomics$41,293
F31 · FY2021 · HL · contact PI
A Patient-Specific hiPSC Model of Nilotinib-Induced Peripheral Artery Disease Pharmacogenomics$45,520
F31 · FY2020 · HL · contact PI